Every Form 4 that CDT Equity Inc. Warrant (CDTTW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CDTTW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CDTTW filings page.
CDT Equity Inc. (symbol: CDT) is the issuer of record for a Form 4 filing submitted to the SEC.
CDT Equity Inc. disclosed that entities associated with major shareholder Mark Taylor sold a combined 2,068,000 shares of Common Stock in open-market transactions on June 18, 2026. Prospect Capital Securities Limited sold 1,469,711 shares at prices including $1.44 and $0.7052 per share, while Prospect Finance Limited sold 598,289 shares at prices including $1.25–$1.67 and $0.751 per share. Following these sales, each entity reported holding zero CDT Equity common shares. The reported share amounts give effect to a 1-for-25 reverse split effective as of March 26, 2026.
CDT Equity Inc. director and CEO Dr. Regan reported indirect purchases and conversions through affiliated entities. On March 24, 2026, Corvus Capital Limited, which he controls, exercised all its pre-funded warrants via cashless exercise into 147,401 shares of Common Stock, eliminating the warrant position. On May 13, 2026, Corvus bought an additional 100,000 shares in the open market at $1.90 per share for total cash consideration of $190,000, bringing Corvus’s reported Common Stock holdings to 256,393 shares. Separate indirect holdings via Manoira Corporation total 773 shares, and Dr. Regan also holds 5,600 shares directly. All share amounts reflect a 1‑for‑25 reverse stock split effected on March 26, 2026.
CDT Equity Inc. reported indirect restructuring transactions involving entities associated with Mark Taylor. On February 19, 2026, Prospect Finance Limited transferred 46,902 shares of Common Stock and pre-funded warrants to purchase 9,968,931 shares of Common Stock to a third party for no consideration.
Following stockholder approval at a special meeting, on March 17, 2026 Prospect Capital Securities Limited and Prospect Finance Limited cashlessly exercised all of their remaining Pre-Funded Warrants and received 36,544,028 and 14,876,330 CDT Equity Common shares, respectively. Mark Taylor is the sole director and shareholder of both entities and may be deemed to beneficially own these securities, but he disclaims beneficial ownership except to the extent of his pecuniary interest.
CDT Equity Inc. director Farley Chele Chiavacci reported acquiring new equity-linked interests in connection with a share purchase deal. On February 19, 2026, the director agreed to transfer 18 shares of Sarborg Limited, valued at about $2,029,411, to CDT Equity.
As consideration, the director received 10,553 shares of CDT common stock and pre-funded warrants to purchase up to 1,940,804 CDT common shares at $1.04 per share. These pre-funded warrants cannot be exercised until CDT obtains requisite stockholder approval under Nasdaq Listing Rule 5635 and will remain exercisable until they are fully exercised.
On September 19, 2025, CDT Equity Inc. granted Dr. Andrew Regan 1,120,000 shares of common stock under its Amended and Restated 2023 Stock Incentive Plan as compensation for his services as a director and officer. The grant price reported reflects the closing price on September 18, 2025 at $0.6863 per share. After the grant, Dr. Regan directly beneficially owns 1,120,044 shares and also may be deemed to beneficially own additional shares held of record by Manoira Corporation, Corvus Capital Ltd., and Algo Holdings, Inc., entities connected to him by ownership and control.
James Bligh, CFO and Director of CDT Equity Inc. (CDT), was granted 480,000 shares of restricted common stock on 09/19/2025. The restricted shares were granted under the company's Amended and Restated 2023 Stock Incentive Plan and, according to the filing, vest immediately upon grant. The filing states the award had an approximate value of $329,424 based on the issuer's closing share price on 09/18/2025. After the reported transaction the Form 4 shows 480,024 shares beneficially owned by the reporting person in a direct ownership form. The filing is signed by James Bligh on 09/19/2025.